US6551872012 - Common Stock
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top gainers and losers in today's session.
Which stocks are moving before the opening bell on Friday?
Which stocks are moving after the closing bell on Thursday?
What's going on in today's session
Curious about the most active stocks on Thursday? Find out which stocks are dominating the market action!
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
LIFEHAB is a randomized controlled trial in Norway comparing lumbar interbody fusion surgery with multidisciplinary rehabilitation Norway is a...
BROOMFIELD, CO - (NewMediaWire) - April 23, 2024 - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 at 11 am PT. Brent Ness, CEO of Aclarion, Inc. will be hosting the presentation and answering questions at the conclusion.
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
It's time to check out all of the biggest pre-market stock movers worth watching on with the winners and losers of Tuesday!
Pre-market stock movers are the perfect way to start the week as we dive into the biggest stories moving shares on Monday!
Confirms predictive value of Nociscan for identifying painful discs.
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
BROOMFIELD, CO - (NewMediaWire) - February 27, 2024 - Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, today announced the closing of its public offering of 5,175,000 units, with each unit consisting of one share of common stock (or one pre-funded warrant in lieu thereof), and two common warrants, with each common warrant to purchase one share of common stock. Each unit was sold at a public offering price of $0.58. The common warrants are immediately exercisable at a price of $0.58 per share and expire five years from the date of issuance. The shares of common stock (or pre-funded warrants in lieu thereof) and accompanying warrants were only purchasable together in this offering, but were issued separately and immediately separable upon issuance.
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
BROOMFIELD, CO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare...
Aclarion (ACON) announced a public offering of 5.18M units, leading to a sharp decline in premarket trading.
Altimmune stock is rising higher on Monday as ALT investors react to positive news from rival weight loss drugmaker Zealand Pharma.
BROOMFIELD, CO - (NewMediaWire) - February 26, 2024 - Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, today announced the pricing of its public offering of 5,175,000 units, with each unit consisting of one share of common stock (or one pre-funded warrant in lieu thereof), and two common warrants, with each common warrant to purchase one share of common stock. Each unit is being sold at a public offering price of $0.58. The common warrants will be immediately exercisable at a price of $0.58 per share and will expire five years from the date of issuance. The shares of common stock (or pre-funded warrants in lieu thereof) and accompanying common warrants can only be purchased together in this offering, but will be issued separately and will be immediately separable upon issuance.
BROOMFIELD, CO - (NewMediaWire) - February 26, 2024 - Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, today announced the pricing of its public offering of 5,175,000 units, with each unit consisting of one share of common stock (or one pre-funded warrant in lieu thereof), and two common warrants, with each common warrant to purchase one share of common stock. Each unit is being sold at a public offering price of $0.58. The common warrants will be immediately exercisable at a price of $0.58 per share and will expire five years from the date of issuance. The shares of common stock (or pre-funded warrants in lieu thereof) and accompanying common warrants can only be purchased together in this offering, but will be issued separately and will be immediately separable upon issuance.
BROOMFIELD, CO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare...
Intuitive Machines stock is falling on Monday as investors in LUNR react to an update on the company's lunar landing last week.
Aclarion stock is falling on Monday as investors react to news of a public offering for shares of ACON and a delisting update.
We're starting the trading week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning!